The present landscape of clinical studies is rapidly evolving, spurred by innovative approaches to therapeutic design. From tailored medicine, leveraging biological data to direct treatment strategies, to the investigation of sophisticated immunotherapies, practitioners are witnessing a fundamental shift in how we address disease. A critical focus